Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly prescribed for type 2 diabetes and weight loss
For patients at Tucson Wellness MD, this medication offers several distinct advantages over previous options: Weight-Loss Results in Clinical Research Clinical data suggests that Retatrutide may yield higher percentages of body weight loss compared to dual-agonist medications, making it a investigational option being studied for obesity treatment
In addition, the incretin hormones slow gastric emptying, thereby delaying the absorption of food (and, in particular, glucose) a further mechanism in reducing post-meal hyperglycaemia
When Does TrimRx Fit Your Situation
However, the study urges further research into how semaglutide use during lactation might affect milk production and composition, given the potential for rapid weight loss and its implications for maternal and infant nutrition